ND 1204 Lecture 1: Medicamentos_esenciales_2011_CVCFT_2011_documento_CUFAR_lect
Document Summary
Paul a komesaroff, professor of medicine, director, centre for the study of ethics in. Medicine and society, monash university department of medicine, alfred hospital, Melbourne, and ethics convener, royal australasian college of physicians. In answer to these concerns a range of responses has developed, including rules set by government, processes for the review and management of research, industry codes of conduct, community responses, and guidelines generated by practitioner associations. Although guidelines for health professionals provide some advice, they cannot cover all situations where conflicts and dualities may arise in practice. Key words: drug promotion, drug regulation, ethics. (aust prescr 2007;30:150 3) While it may be true that the industry"s negative reputation is not completely justified, it is not difficult to understand the source of the concerns. General practitioners and other health professionals such as pharmacists are frequently visited by representatives of pharmaceutical companies. The purpose of these visits is to promote the company"s drugs and to build a relationship.
